• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Science Looking Forward Report

Description: At Commissioner Hamburg's request, a subcommitte of the Science Board has been formed to review the state of science at FDA, highlighting the current strengths of regulatory science at FDA and evaluating the Agency’s readiness and needs looking forward to future challenges.

Briefing Status: DELAYED

Prior Briefing Status: DELAYED

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Prepare the charge to the Science Board


Completed 6/24/2013

B. Establish a Science Board subcommittee


Completed 11/1/2013

C. Develop an internal working group to prepare materials for subcommittee


Completed 12/1/2013

D. Develop background material and propose priority future activities for the subcommittee to consider


Completed 6/24/2014

E. Submit background material to subcommittee for review


Completed 6/30/2014

F. Meet with subcommittee for additional input (site visit)




G. Prepare draft report




H. Present report to Science Board



Not Yet Started

I. Finalize report



Not Yet Started


  • The dates in italics are modified milestone due dates that have been updated due to real-time delays. The milestone status reflects the current reporting quarter’s status. If a milestone is missed, the milestone will remain delayed until the milestone is completed.

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.